Home / Business and Economy / Nephrocare IPO: Dialysis Giant Aims for ₹871 Crore
Nephrocare IPO: Dialysis Giant Aims for ₹871 Crore
10 Dec, 2025
Summary
- Nephrocare, India's largest dialysis provider, launches ₹871 crore IPO.
- Company operates an asset-light model with 52.4% clinics on revenue sharing.
- Net profit doubled in FY25 to ₹67 crore; revenue rose 33.5%.
Nephrocare Health Services, India's largest dialysis provider, is set to launch its ₹871 crore Initial Public Offering (IPO) from December 10 to December 12. The company, which operates the NephroPlus brand, has secured ₹260 crore from anchor investors ahead of the launch.
Following an asset-light and capital-efficient model, 52.4% of its clinics operate on revenue-sharing, minimizing investment in space. Nephrocare's financial performance shows robust growth, with net profit nearly doubling to ₹67 crore in the fiscal year 2025 and revenue increasing by 33.5% to ₹755.8 crore.
The IPO aims to raise ₹353.4 crore through a fresh issue, with proceeds allocated to opening new clinics in India and debt repayment. Promoters and existing investors will also sell shares through an offer for sale. The company has a significant presence, with 519 clinics globally, including 51 international centers.
